Download PDF
Exp Clin Endocrinol Diabetes 2016; 124(01): 55-60
DOI: 10.1055/s-0035-1564094
Article
© Georg Thieme Verlag KG Stuttgart · New York

β-endorphins Plasma Level is Higher in Lean Polycystic Ovary Syndrome (PCOS) Women

M. Kiałka
1   Department of Gynecological Endocrinology, Jagiellonian University, Medical College, Cracow, Poland
,
T. Milewicz
1   Department of Gynecological Endocrinology, Jagiellonian University, Medical College, Cracow, Poland
,
M. Spałkowska
2   Department of Dermatology, Jagiellonian University, Medical College, Cracow, Poland
,
M. Krzyczkowska-Sendrakowska
1   Department of Gynecological Endocrinology, Jagiellonian University, Medical College, Cracow, Poland
,
B. Wasyl
3   Department of Pediatrics, L. Rydygiera Hospital in Brzesko, Poland
,
A. Pełka
3   Department of Pediatrics, L. Rydygiera Hospital in Brzesko, Poland
,
J. Krzysiek
1   Department of Gynecological Endocrinology, Jagiellonian University, Medical College, Cracow, Poland
› Author Affiliations
Further Information

Publication History

received 15 April 2015
first decision 02 August 2015

accepted 25 August 2015

Publication Date:
21 January 2016 (online)

Also available at
    Permissions and Reprints

Abstract

Aim: The evaluation the β-endorphin plasma levels in lean women with polycystic ovary syndrome as well as in women without this disorder. The associations between β-endorphins and other laboratory parameters were also investigated.

Materials and methods: 31 women lean, defined as women with normal range body mass index, 15 with polycystic ovary syndrome and 16 without this disorder were included to the study. In all the patients the level of β-endorphins was measured. Also the diagnostic laboratory profile including hormone assessment was made in all patients.

Results: There were significant differences in β-endorphin levels between the 2 groups. The β-endorphin level was higher in the polycystic ovary syndrome group compared to the healthy controls (15.5±4.37 pg/ml vs. 6.9±2.47 pg/ml, p<0.0001). The β-endorphin levels positively correlated with cortisol at 8 am (R=0.632, p=0.011) and negatively correlated with sex hormone binding globuline (R=0.518, p=0.0478) in polycystic ovary syndrome group. Increase in β-endorphin level of 1 pg/ml was associated with an increase of cortisol at 8 am level of 1.134 µg/dl and decrease of sex hormone binding globuline of 0.948 nmol/l in polycystic ovary syndrome group.

Conclusion: Our study showed that the levels of β-endorphins were significantly higher in lean patients with polycystic ovary syndrome than in lean controls. Moreover, β-endorphins levels were found to be correlated with other hormonal parameters. In this respect, β-endorphins may play a role in polycystic ovary syndrome pathophysiology.

Key words

opioids - pcos - lean women
 

  • References

  • 1 Eyvazzadeh AD, Pennington KP, Pop-Busui R et al. The role of the endogenous opioid system in polycystic ovary syndrome. Fertility and Sterility 2009; 92: 1-12
    CrossrefPubMedGoogle Scholar
  • 2 Azziz R. Diagnosis of polycystic ovarian syndrome: The rotterdam Criteria are premature. JCEM 2006; 91: 781-785
    PubMedGoogle Scholar
  • 3 Azziz R, Carmina E, Dewailly D et al. The Androgen Exsess and PCOS Society criteria for the polycystic ocary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488
    CrossrefPubMedGoogle Scholar
  • 4 Ahmed MI, Duleba AJ, El Shahat O et al. Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. Human Reproduction 2008; 23: 2564-2569
    CrossrefPubMedGoogle Scholar
  • 5 Guido M, Romualdi D, Lanzone A. Role of opioid antagonists in the treatment of women with glucoregulation Abnormalities. Curr Pharm Des 2006; 12: 1001-1012
    CrossrefPubMedGoogle Scholar
  • 6 Marshall JC, Eagleson CA. Neuroendocrine aspects of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28: 295-324
    CrossrefPubMedGoogle Scholar
  • 7 Arora S. Role of neuropeptides in appetite regulation and obesity – a review. Neuropeptides 2006; 40: 375-401
    CrossrefPubMedGoogle Scholar
  • 8 Barbieri RL, Smith S, Ryan J. The role of hyperandrogenemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril 1988; 50: 197-210
    PubMedGoogle Scholar
  • 9 Frager MS, Pieper DR, Tonetta SA et al. Pituitary gonadotropin-releasing hormone receptors. Effects of castration, steroid replacement and the role of gonadotropin-releasing hormone in modulating receptors in rat. J Clin Invest 1981; 67 (615) 623
    PubMedGoogle Scholar
  • 10 Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol 1993; 39: 1-16
    CrossrefPubMedGoogle Scholar
  • 11 Pasquali R, Vicennati V. Activity of the hypothalamic-pituitary-adrenalaxis in different obesity phenotypes. Int J Obes Relat Metab Disord 2000; 24: S47-S49
    CrossrefPubMedGoogle Scholar
  • 12 http: //www.phoenixpeptide.com/catalog/repository/QCdata_RIK/RK-022-14.pdf
    PubMed
  • 13 Wortsman J, Wehrenberg WB, Gavin JR et al. Elevated levels of plasma betaendorphin and melanocyte stimulating hormone in the polycystic ovary syndrome. Obstet Gynecol 1984; 63: 630-635
    PubMedGoogle Scholar
  • 14 Givens JR, Wiedman E, Andersen RN et al. β-endorphin and β-lipotropin plasma levels in hirsute women correlation with body weight. J Clin Metab 1980; 50: 975-976
    CrossrefPubMedGoogle Scholar
  • 15 Genazzani AR, Facchinetti F, Petraglia F et al. Hyperendorphinemia in obese children and adolescents. J Clin Metab 1986; 62: 36-40
    CrossrefPubMedGoogle Scholar
  • 16 Lackey BR, Gray SL, Henricks DM et al. The insulin-like growth factor(IGF) system and gonadotropin regulation: actions and interactions. Cytokine Growth Factor Rev 1999; 10: 201-217
    CrossrefPubMedGoogle Scholar
  • 17 Giugliano D, Ceriello A, Salvatore T et al. b-Endorphin infusion restores acute insulin response to glucose in type-II diabetes mellitus. J Clin Endocrinol Metab 1978; 64: 944-948
    PubMedGoogle Scholar
  • 18 Feldmann M, Kiser RS, Unger RH et al. β-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings. N Engl J Med 1983; 308: 349-353
    CrossrefPubMedGoogle Scholar
  • 19 Reid RL, Yen SSC. Beta-endorphin stimulates the secretion of insulinand glucagon in humans. J Clin Endocrinol Metab 1981; 52: 592-594
    CrossrefPubMedGoogle Scholar
  • 20 Lanzone A, Fulghesu AM, Fortini A et al. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. Hum Reprod 1991; 6: 1043-1049
    PubMedGoogle Scholar
  • 21 Nestler JE, Jakubowicz DJ, De Vrgas AF et al. Insulin stimulates testosterone biosynthesis by human thecal cell from women with polycystic ovary syndrome by activating its own receptor and using inositoglycan mediators as the signal transduction system. J Clin Endocrinol Metab 1998; 83: 2001-2005
    CrossrefPubMedGoogle Scholar
  • 22 Fulghesu AM, Ciampelli M, Fortini A et al. Effect of opioid blockade on insulin metabolism in polycysticovarian disease. Hum Reprod 1995; 10: 2253-2257
    CrossrefPubMedGoogle Scholar
  • 23 Dunaif A, Segal KR, Futterwiet W. Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 1989; 38: 1165-1174
    CrossrefPubMedGoogle Scholar
  • 24 Yen SSC, Vela P, Rankin J. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease, hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol Metab 1970; 30: 435-442
    CrossrefPubMedGoogle Scholar
  • 25 Veldhuis JD, Rogol AD, Samojlik E et al. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. J Clin Invest 1985; 74: 47-55
    PubMedGoogle Scholar
  • 26 Lanzone A, Fulghesu AM, Cucinelli F et al. Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion. J Clin Endocrinol Metab 1995; 80: 3501-3506
    PubMedGoogle Scholar
  • 27 Petraglia F, Di Meo G, De Leo V et al. Plasma B-endorhpin levels in anovulatory states: changes after treatments for the induction of ablation. Fertil Steril 1986; 45: 185-190
    PubMedGoogle Scholar
  • 28 Aleem FA, McIntosh T. Elevated plasma levels of β-endorphin in a group of women with polycystic ovarian disease. Fertil Steril 1984; 42: 686-689
    PubMedGoogle Scholar
  • 29 Carmina E, Ditkoff EC, Malizia G et al. Increased circulating levels of immunoreactive b-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion. Am J Obstet Gynecol 1992; 167: 1819-1824
    CrossrefPubMedGoogle Scholar
  • 30 Nestler JE, Powers LP, Matt DW et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 1991; 72: 83-89
    CrossrefPubMedGoogle Scholar
  • 31 Prelević GM, Würzburger MI, Balint-Perić L et al. 24-h serum cortisol profiles in women with polycystic ovary syndrome. Gynecol Endocrinol 1993; 7: 179-184
    CrossrefPubMedGoogle Scholar
  • 32 Lobo RA, Granger LR, Paul WL et al. Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. Am J Obstet Gynecol 1983; 145: 496-503
    CrossrefPubMedGoogle Scholar
  • 33 Fruzzetti F, Bersi C, Parrini D et al. Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertil Steril 2002; 77: 936-944
    CrossrefPubMedGoogle Scholar
  • 34 Tropeano G, Lucisano A, Liberale I et al. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 1994; 78: 305-309
    PubMedGoogle Scholar
  • 35 Mansson M, Holte J, Landin-Wilhelmsen K et al. Women with polycycstic obary syndrome are often depressed or anxious – a case control study. Psychoneuroendocrinology 2008; 33: 1132-1138
    CrossrefPubMedGoogle Scholar
  • 36 Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycyctsic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2011; 26: 2442-2251
    CrossrefPubMedGoogle Scholar